The efficacy and safety of anlotinib treatment for advanced lung cancer

L Shao, W Wang, Z Song, Y Zhang - OncoTargets and therapy, 2019 - Taylor & Francis
Objective Anlotinib is an oral novel multi-target tyrosine kinase inhibitor targeting vascular
endothelial growth factor receptor, fibroblast growth factor receptor, platelet-derived growth …
被引用次数：33 相关文章

The efficacy and safety of anlotinib treatment for advanced lung cancer

L Shao, W Wang, Z Song… - OncoTargets and …, 2019 - pubmed.ncbi.nlm.nih.gov
Objective Anlotinib is an oral novel multi-target tyrosine kinase inhibitor targeting vascular
endothelial growth factor receptor, fibroblast growth factor receptor, platelet-derived growth …

The efficacy and safety of anlotinib treatment for advanced lung cancer

L Shao, W Wang, Z Song, Y Zhang - OncoTargets and Therapy, 2019 - go.gale.com
Objective: Anlotinib is an oral novel multi-target tyrosine kinase inhibitor targeting vascular
endothelial growth factor receptor, fibroblast growth factor receptor, platelet-derived growth …
[PDF] semanticscholar.org

[PDF][PDF] The efficacy and safety of anlotinib treatment for advanced lung cancer

L Shao, W Wang, Z Song… - OncoTargets and …, 2019 - pdfs.semanticscholar.org
Objective: Anlotinib is an oral novel multi-target tyrosine kinase inhibitor targeting vascular
endothelial growth factor receptor, fibroblast growth factor receptor, platelet-derived growth …
[PDF] scienceopen.com

[PDF][PDF] The efficacy and safety of anlotinib treatment for advanced lung cancer

L Shao, W Wang, Z Song, Y Zhang - OncoTargets and Therapy, 2019 - scienceopen.com
Objective: Anlotinib is an oral novel multi-target tyrosine kinase inhibitor targeting vascular
endothelial growth factor receptor, fibroblast growth factor receptor, platelet-derived growth …

The efficacy and safety of anlotinib treatment for advanced lung cancer

L Shao, W Wang, Z Song, Y Zhang - OncoTargets and Therapy, 2019 - dovepress.com
Objective: Anlotinib is an oral novel multi-target tyrosine kinase inhibitor targeting vascular
endothelial growth factor receptor, fibroblast growth factor receptor, platelet-derived growth …
[HTML] nih.gov

[HTML][HTML] The efficacy and safety of anlotinib treatment for advanced lung cancer

L Shao, W Wang, Z Song, Y Zhang - OncoTargets and therapy, 2019 - ncbi.nlm.nih.gov
Objective Anlotinib is an oral novel multi-target tyrosine kinase inhibitor targeting vascular
endothelial growth factor receptor, fibroblast growth factor receptor, platelet-derived growth …

The efficacy and safety of anlotinib treatment for advanced lung cancer.

L Shao, W Wang, Z Song, Y Zhang - Oncotargets and Therapy, 2019 - europepmc.org
Objective Anlotinib is an oral novel multi-target tyrosine kinase inhibitor targeting vascular
endothelial growth factor receptor, fibroblast growth factor receptor, platelet-derived growth …

The efficacy and safety of anlotinib treatment for advanced lung cancer.

L Shao, W Wang, Z Song, Y Zhang - Oncotargets and Therapy, 2019 - europepmc.org
Objective Anlotinib is an oral novel multi-target tyrosine kinase inhibitor targeting vascular
endothelial growth factor receptor, fibroblast growth factor receptor, platelet-derived growth …